ES516205A0 - Mejoras introducidas en la manufactura de un inserto ocular biosoluble. - Google Patents

Mejoras introducidas en la manufactura de un inserto ocular biosoluble.

Info

Publication number
ES516205A0
ES516205A0 ES516205A ES516205A ES516205A0 ES 516205 A0 ES516205 A0 ES 516205A0 ES 516205 A ES516205 A ES 516205A ES 516205 A ES516205 A ES 516205A ES 516205 A0 ES516205 A0 ES 516205A0
Authority
ES
Spain
Prior art keywords
biosoluble
manufacture
improvements introduced
eye insert
insert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES516205A
Other languages
English (en)
Other versions
ES8401317A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES516205A0 publication Critical patent/ES516205A0/es
Publication of ES8401317A1 publication Critical patent/ES8401317A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
ES516205A 1981-10-08 1982-10-04 Mejoras introducidas en la manufactura de un inserto ocular biosoluble. Expired ES8401317A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30985281A 1981-10-08 1981-10-08

Publications (2)

Publication Number Publication Date
ES516205A0 true ES516205A0 (es) 1983-12-16
ES8401317A1 ES8401317A1 (es) 1983-12-16

Family

ID=23199947

Family Applications (1)

Application Number Title Priority Date Filing Date
ES516205A Expired ES8401317A1 (es) 1981-10-08 1982-10-04 Mejoras introducidas en la manufactura de un inserto ocular biosoluble.

Country Status (9)

Country Link
EP (1) EP0077261B1 (es)
JP (1) JPS5875547A (es)
AT (1) ATE28562T1 (es)
CA (1) CA1219213A (es)
DE (1) DE3276848D1 (es)
DK (1) DK444482A (es)
ES (1) ES8401317A1 (es)
GR (1) GR77712B (es)
PT (1) PT75625B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1223150B (it) * 1987-11-18 1990-09-12 Ubaldo Conte Compressa per uso oftalmico e rilascio controllato della sostanza attiva
SG84487A1 (en) 1991-04-17 2001-11-20 Merck & Co Inc Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a b-adrenergic antagonist
FR2688694B1 (fr) * 1992-03-20 1999-06-25 Vetoquinol Sa Insert ophtalmique bioadhesif.
AU5092493A (en) * 1992-09-08 1994-03-29 Allergan, Inc. Sustained release of ophthalmic drugs from a soluble polymer drug delivery vehicle
MY113268A (en) * 1992-12-29 2002-01-31 Insite Vision Incorporated Plasticized bioerodible controlled delivery system
US5773021A (en) * 1994-03-14 1998-06-30 Vetoquinol S.A. Bioadhesive ophthalmic insert
US6316443B1 (en) 1994-08-04 2001-11-13 Merck & Co., Inc. Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a β-adrenergic antagonist
US20050042194A1 (en) 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US6613355B2 (en) 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US8067433B2 (en) 2005-11-09 2011-11-29 Zalicus Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
US7845537B2 (en) 2006-01-31 2010-12-07 Ethicon Endo-Surgery, Inc. Surgical instrument having recording capabilities
TWI826685B (zh) 2019-05-02 2023-12-21 瑞士商愛爾康公司 可溶解聚合物眼睛插入物及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE352811B (es) * 1971-06-04 1973-01-15 Pharmacia Ab
FR2148959A5 (es) * 1971-08-13 1973-03-23 Alza Corp
SE375007B (es) * 1972-11-30 1975-04-07 Pharmacia Ab
US3968201A (en) * 1972-11-30 1976-07-06 Pharmacia Aktiebolag Dosage unit containing a substance showing a topical effect on the eye, and a method of preparing same
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent

Also Published As

Publication number Publication date
CA1219213A (en) 1987-03-17
PT75625B (en) 1985-12-09
JPS5875547A (ja) 1983-05-07
DK444482A (da) 1983-04-09
GR77712B (es) 1984-09-25
EP0077261A2 (en) 1983-04-20
ATE28562T1 (de) 1987-08-15
EP0077261B1 (en) 1987-07-29
DE3276848D1 (de) 1987-09-03
PT75625A (en) 1982-10-01
EP0077261A3 (en) 1984-03-28
ES8401317A1 (es) 1983-12-16

Similar Documents

Publication Publication Date Title
IT209382Z2 (it) Cristallino artificiale per la camera anteriore dell'occhio.
NO891909D0 (no) Implantat for brytningskorreksjon i et oeyes forkammer.
ZA872624B (en) Medicament for the treatment of inflammations of the eye
DE3276848D1 (de) Biosoluble ocular insert
FI904888A0 (fi) Foerfarande foer framstaellning av ett oestrogenhaltigt medikamentplaoster.
NZ192541A (en) Reducing "sharkskin" melt fracture during extrusion of molten polymer
ATE57606T1 (de) Flexible, intraokulare linsenhalterung.
IT8941653A0 (it) Dispositivo per la correzione delle anomalie di rifrazione dell'occhio.
DK266889A (da) Doseringsformer med reguleret afgivelse med et bestemt vandindhold
MY103224A (en) 2-(2''-hydroxpphenyl)-5(6)-(acryloyloxyalkoxy)- benzotrialzole and ultraviolet absorbing polymers therefrom
KR900701323A (ko) 신규한 녹내장 치료용 안과 제제
EP0422068A4 (en) Pharmacological treatment of ocular development
EP0295049A3 (en) Thiophene sulfonamide antiglaucoma agents
EP0150063A3 (en) Therapeutic and/or preventive ophthalmic solution for intraocular hypertension and glaucoma
IT8848336A0 (it) Lente intraoculare per la correzione dell'ametropia
ATE71227T1 (de) Im wesentlichen nicht quellbare kontaktlinse, die blockcopolymere mit polysiloxan-polyoxyalkylen- einheiten in der hauptkette enthaelt.
PH18764A (en) Method for treating glaucoma ba the optical administration of selectively metabolized betablocking agents
IT1179308B (it) Lente intraoculare impiantabile in camera posteriore
FR2409717A1 (fr) Semelle avec talon pour chaussures de dames et procede particulier de leur fabrication rapide et economique
FR2612766B1 (fr) Cristallin artificiel de l'oeil
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
ES273020Y (es) "protesis ocular"
ES508228A0 (es) Perfeccionamientos en el objeto de la patente principal n 487.507(9) por "maquina biseladora automatica de cristales opticos".
IT7826629A0 (it) Preparato oftalmico per l'uso nel trattamento di malattie degli occhi in mammiferi
JPS549286A (en) Optical active isocarbostyryl derivatives and process for their preparation